RT-PCR splicing analysis of the NF1 open reading frame

Human Genetics

Volumn 110, Issue 5, 2002, Pages 495-502

  Thomson, Sussanne A M ^a,b   Wallace, Margaret R ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; ISOPROTEIN; RNA;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD SAMPLING; BRAIN; CEREBELLUM; CODON; CONTROLLED STUDY; EXON; FETUS LIVER; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SCREENING; HEART; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROFIBROMATOSIS; NONSENSE MUTATION; OPEN READING FRAME; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SCHWANN CELL; SPINAL CORD; TEMPERATURE;

ALTERNATIVE SPLICING; EXONS; HUMANS; MUTATION; NEUROFIBROMIN 1; OPEN READING FRAMES; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHWANN CELLS; TEMPERATURE; TIME FACTORS;

EID: 0036590139     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0714-6     Document Type: Article

References (32)

1. Abernathy CR, Rasmussen SA, Stalker HJ, Zori R, Driscoll DJ, Williams CA, Kousseff BG, Wallace MR (1997) NF1 Mutation Analysis Using a Combined Heteroduplex/SSCP Approach. 9:548-554
2. Andersen LB, Ballester R, Marchuk DA, Chang E, Gutman DH, Saulino AM, Camonis J, Wigler M, Collins FS (1993) A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene products two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol 13:487-495
3. Ars E, Serra E, Garcia J, Kruyer H, Gaona A, Lazaro C, Estivill X (2000a) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9:237-247
4. Ars E, Serra E, De La Luna S, Estivill X, Lazaro C (2000b) Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA. Nucleic Acids Res 28:1307-1312
5. Colman SD, Abernathy CR, Ho VT, Wallace MR (1997) Four frameshift mutations in neurofibromatosis type 1 caused by small insertions. J Med Genet 34:579-581
6. Danglot G, Regnier V, Fauvet D, Vassal G, Kujas M, Bernheim A (1995) Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5′ part of the gene. Hum Mol Genet 4:915-920
7. Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, Kucukceylan N, Abdel-Nour M, Gewies A, Peters H, Kaufmann D, Buske A, Tinschert S, Nurnberg P (2000) Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 66:790-818
8. Friedman JM, Gutmann DH, MacCollin M, Riccardi VM (1999) Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd edn. Johns Hopkins University Press, Baltimore
9. Gutmann DH, Andersen LB, Cole JL, Swaroop M, Collins FS (1993) An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle. Hum Mol Genet 2:989-992
10. Heim RA, Kam-Morgan LN, Binnie CG, Corns DD, Cayouette MC, Farber RA, Alyslworth AS, Silverman LM, Luce MC (1995) Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4:975-981
11. Hoffmeyer S, Nurnberger P, Ritter H, Fahsold R, Leistner W, Kaufmann D, Krone W (1998) Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. Am J Hum Genet 62:269-277
12. Liu HX, Cartegni L, Zhang MQ, Krainer AR (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27:55-58
13. Madison L, Hoar D, Holroyd C, Crisp M, Hodes M (1987) DNA banking: The effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet 27:379-390
14. Messiaen L, Callens T, De Paepe A, Craen M, Mortier G (1997) Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene. Hum Genet 101:75-80
15. Messiaen L, Callens T, Roux K, Mortier G, DePaepe A, Abramowicz M, Pericak-Vance M, Vance J, Wallace M (1999) Exon 10b of the NF1 gene represents a mutational hot spot and harbors a missense mutation Y489C associated with aberrant splicing in unrelated patients. Genet Med 1:248-253
16. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15:541-555
17. Muir D, Neubauer D, Lim IT, Yachnis AT, Wallace MR (2001) Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells. Am J Pathol 158:501-513
18. Park VM, Pivnick EK (1998) Neurofibromatosis type 1 (NF1): A protein truncation assay yielding identification of mutations in 73% of patients. J Med Genet 35:813-820
19. Park VM, Kenwright KA, Sturtevant DB, Pivnick EK (1998) Alternative splicing of exons 29 and 30 in the neurofibromatosis type 1 gene. Hum Genet 103:382-385
20. Robinson PN, Boddrich A, Peters H, Tinschert S, Buske A, Kaufmann D, Nurnberg P (1995) Two recurrent nonsense mutations and a 4 bp deletion in a quasi- symmetric element in exon 37 of the NF1 gene. Hum Genet 96:95-98
21. Rutkowski JL, Wu K, Gutmann DH, Boyer PJ, Legius E (2000) Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet 9:1059-1066
22. Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, Estivill X, Lenard HG, Lazaro C (2000) Schwann cells harbor the somatic NF1 mutation in neurofibromas: Evidence of two different Schwann cell subpopulations. Hum Mol Genet 9:3055-3064
23. Shiga N, Takeshima Y, Sakamoto H, Inoue K, Yokota Y, Yokoyama M, Matsuo M (1997) Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker musuclar dystrophy. J Clin Invest 100:2204-2210
24. Upadhyaya M, Cooper DN (1998) Neurofibromatosis Type 1: From Genotype to Phenotype. BIOS Scientific, Oxford
25. Upadhyaya M, Osborn MJ, Maynard J, Kim MR, Tamanoi F, Cooper DN (1997) Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 99:88-92
26. Viskochil D (1999) Neurofibromatosis 1. Am J Med Genet 89:5-8
27. Vockley J, Rogan PK, Anderson BD, Willard J, Seelan RS, Smith DI, Liu W (2000) Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. Am J Hum Genet 66:356-367
28. Wallace M, MacCollin M (2001) Genetics of NF1 and NF2. In: Colwell JK (ed) Molecular Genetics of Cancer, 2nd edn. BIOS Scientific, Oxford, pp 95-113
29. Wallace M, Trimpert R, Thomson S, Fishbein L, Abernathy C (1998) Cryptic out-of-frame NF1 exon splicing in neurofibromas. Am J Hum Genet 63 (Suppl):A90
30. Wallace MR, Rasmussen SA, Lim IT, Gray BA, Zori RT, Muir D (2000) Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors. Genes Chromosom Cancer 27:117-123
31. Wimmer K, Eckart M, Stadler PF, Rehder H, Fonatsch C (2000a) Three different premature stop codons lead to skipping of exon 7 in neurofibromatosis type I patients. Hum Mutat 16:90-91
32. Wimmer K, Eckart M, Rehder H, Fonatsch C (2000b) Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients. Hum Genet 106:311-313